Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1996 | 12-1995 | 12-1994 | 12-1993 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 9,575 | 36 | N/A | N/A |
| Marketable Securities | 11,030 | 30 | 640 | 640 |
| Receivables | 530 | 170 | 80 | N/A |
| Inventories | 700 | 560 | 340 | N/A |
| Other current assets | -9,825 | -276 | -150 | 0 |
| TOTAL | $12,010 | $520 | $910 | $640 |
| Non-Current Assets | ||||
| PPE Net | 596 | 477 | N/A | N/A |
| Other Non-Current Assets | 340 | 230 | 0 | 0 |
| TOTAL | $936 | $707 | $N/A | $N/A |
| Total Assets | $12,950 | $1,240 | $1,360 | $890 |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 90 | 340 | 200 | N/A |
| Accounts payable and accrued liabilities | 350 | 240 | 160 | 0 |
| Other current liabilities | 340 | 540 | 400 | N/A |
| TOTAL | $820 | $1,170 | $800 | $N/A |
| Non-Current Liabilities | ||||
| Long Term Debt | 8 | 136 | N/A | N/A |
| TOTAL | $17 | $176 | $80 | $N/A |
| Total Liabilities | $837 | $1,314 | $880 | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 60 | 2 | 2 | N/A |
| Retained earnings | -11,540 | -9,300 | -7,410 | -6,350 |
| Other shareholders' equity | 0 | 38 | 18 | 6,460 |
| TOTAL | $12,110 | $-70 | $250 | $110 |
| Total Liabilities And Equity | $12,947 | $1,244 | $1,130 | $110 |